Skip to main content
Top
Published in: Clinical and Experimental Medicine 3/2013

01-08-2013 | Original Article

Significantly higher procalcitonin levels could differentiate Gram-negative sepsis from Gram-positive and fungal sepsis

Authors: Helena Brodská, Karin Malíčková, Václava Adámková, Hana Benáková, Markéta Marková Šťastná, Tomáš Zima

Published in: Clinical and Experimental Medicine | Issue 3/2013

Login to get access

Abstract

Procalcitonin (PCT) levels can distinguish between infectious and non-infectious systemic inflammatory response. However, there are some differences between Gram-negative (G−), Gram-positive (G+), and fungal bloodstream infections, particularly in different cytokine profiles, severity and mortality. The aim of current study was to examine whether PCT levels can serve as a distinguishing mark between G+, G−, and fungal sepsis as well. One hundred and sixty-six septic patients with positive blood cultures were examined on C-reactive protein (CRP) and PCT on the same date of blood culture evaluation. The median (interquartile range, IQR) of CRP and PCT in G+, G−, and fungal cohorts and comparison of measured values between groups were made using the Kruskal–Wallis test with subsequent Bonferroni’s corrections, with p < 0.05. In 83/166 (50 %) of blood cultures, G+ microbes, 78/166 (47 %) G− rods, and 5/166 (3 %) fungi were detected. PCT concentrations (ng/ml) were significantly higher in G− compared to other cohorts: 8.90 (1.88; 32.60) in G−, 0.73 (0.22; 3.40) in G+, and 0.58 (0.35; 0.73) in fungi (p < 0.00001). CRP concentrations did not differ significantly in groups. Significantly higher PCT levels could differentiate G− sepsis from G+ and fungemia. In contrast to CRP, PCT is a good discriminative biomarker in different bloodstream infections.
Literature
1.
go back to reference Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H et al (2006) Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 34:344–353PubMedCrossRef Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H et al (2006) Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 34:344–353PubMedCrossRef
2.
go back to reference ACCP-SCCM Consensus Conference (1992) Definitions of sepsis and multiple organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992(20):864–874 ACCP-SCCM Consensus Conference (1992) Definitions of sepsis and multiple organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992(20):864–874
3.
go back to reference (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis DefinitionsConference. Crit Care Med 31:4 (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis DefinitionsConference. Crit Care Med 31:4
4.
go back to reference Pierrakos CH, Vincent JL (2010) Sepsis biomarkers: a review. Cri Care 14(1):R15CrossRef Pierrakos CH, Vincent JL (2010) Sepsis biomarkers: a review. Cri Care 14(1):R15CrossRef
5.
go back to reference Simon L, Gauvin F, Saint Louis P, Lacroix J (2004) Serum procalcitonin and C-reactive levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 39:206–217PubMedCrossRef Simon L, Gauvin F, Saint Louis P, Lacroix J (2004) Serum procalcitonin and C-reactive levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 39:206–217PubMedCrossRef
6.
go back to reference Reinhart K, Meisner M (2011) Biomarkers in the critically ill patient: procalcitonin. Crit Care Clin 27:253–263PubMedCrossRef Reinhart K, Meisner M (2011) Biomarkers in the critically ill patient: procalcitonin. Crit Care Clin 27:253–263PubMedCrossRef
7.
go back to reference Brunkhorst FM, Wegscheider K, Forycki ZF, Brunkhorst R (2000) Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis and septic shock. Intensive Care Med 26:S148–S152PubMed Brunkhorst FM, Wegscheider K, Forycki ZF, Brunkhorst R (2000) Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis and septic shock. Intensive Care Med 26:S148–S152PubMed
8.
go back to reference Reinhart K, Meisner M (2006) Markers for sepsis diagnosis: what is useful? Crit Care Clin 22:503–519PubMedCrossRef Reinhart K, Meisner M (2006) Markers for sepsis diagnosis: what is useful? Crit Care Clin 22:503–519PubMedCrossRef
9.
go back to reference Gao H, Evans TW, Finney SJ (2008) Bench-to-bedside review: sepsis, severe sepsis and septic shock—does the nature of the infecting organism matter? Crit Care 12(3):213PubMedCrossRef Gao H, Evans TW, Finney SJ (2008) Bench-to-bedside review: sepsis, severe sepsis and septic shock—does the nature of the infecting organism matter? Crit Care 12(3):213PubMedCrossRef
10.
go back to reference Feezor RJ, Oberholzer C, Baker HV, Novick D, Rubinstein M, Moldawer LL et al (2003) Molecular characterization of the acute inflammatory response to infections with gram-negative versus gram-positive bacteria. Infect immune 7:5803–5813CrossRef Feezor RJ, Oberholzer C, Baker HV, Novick D, Rubinstein M, Moldawer LL et al (2003) Molecular characterization of the acute inflammatory response to infections with gram-negative versus gram-positive bacteria. Infect immune 7:5803–5813CrossRef
11.
go back to reference Bjere A, Brusletto B, Holby EA, Kjerulf P, Brandtzaeg P (2004) Plasma Interferon gamma and interleukin 10 concentration in systemic meningococcal disease compared with severe systemic Gram-positive septic shock. Crit Care Med 32:433–438CrossRef Bjere A, Brusletto B, Holby EA, Kjerulf P, Brandtzaeg P (2004) Plasma Interferon gamma and interleukin 10 concentration in systemic meningococcal disease compared with severe systemic Gram-positive septic shock. Crit Care Med 32:433–438CrossRef
12.
go back to reference Mohamed MA, Cunningham-Rundles S, Dean CR, Hammad TA, Nesin M (2007) Levels of proinflammatory cytokines produced from cord blood in vitro are pathogen dependent and increased in comparison to adult controls. Cytokine 39:171–177PubMedCrossRef Mohamed MA, Cunningham-Rundles S, Dean CR, Hammad TA, Nesin M (2007) Levels of proinflammatory cytokines produced from cord blood in vitro are pathogen dependent and increased in comparison to adult controls. Cytokine 39:171–177PubMedCrossRef
13.
go back to reference Charles PE, Ladoire S, Aho S, Quenot JP, Doise JM, Prin S (2008) Serum procalcitonin elevation in critically ill patients at the onset of bacteremia caused by either gram negative or gram positive bacteria. BMC Infect Dis 8:38PubMedCrossRef Charles PE, Ladoire S, Aho S, Quenot JP, Doise JM, Prin S (2008) Serum procalcitonin elevation in critically ill patients at the onset of bacteremia caused by either gram negative or gram positive bacteria. BMC Infect Dis 8:38PubMedCrossRef
14.
go back to reference Abe R, Oda S, Sadahiro T, Nakamura M, Hirayama Y, Tateishi Y (2010) Gram-negative bacteremia induces greater magnitude of inflammatory response than gram-positive bacteremia. Crit Care 14:R27PubMedCrossRef Abe R, Oda S, Sadahiro T, Nakamura M, Hirayama Y, Tateishi Y (2010) Gram-negative bacteremia induces greater magnitude of inflammatory response than gram-positive bacteremia. Crit Care 14:R27PubMedCrossRef
15.
go back to reference Martini A, Gottin L, Menestrina N, Schweiger V, Simion D, Vincent JL (2010) Procalcitonin levels in surgical patients at risk of candidemia. J Infect 60:425–430PubMedCrossRef Martini A, Gottin L, Menestrina N, Schweiger V, Simion D, Vincent JL (2010) Procalcitonin levels in surgical patients at risk of candidemia. J Infect 60:425–430PubMedCrossRef
16.
go back to reference Montagna MT, Coretti C, Caggiano P (2011) Procalcitonin: a possible marker of invasive fungal infection in high risk patients? J Prev Hyg 52:38–39 Montagna MT, Coretti C, Caggiano P (2011) Procalcitonin: a possible marker of invasive fungal infection in high risk patients? J Prev Hyg 52:38–39
17.
go back to reference Vincent JL, Donadello K, Schmidt X (2011) Biomarkers in the critically ill patient: C-reactive protein. Crit Care Clin 27:241–251PubMedCrossRef Vincent JL, Donadello K, Schmidt X (2011) Biomarkers in the critically ill patient: C-reactive protein. Crit Care Clin 27:241–251PubMedCrossRef
18.
go back to reference Delevaux I, Andre M, Colombier M, Albuisson E, Meylheuc F, Bégueet RJ (2003) Can procalcitonin measurement help in differentiating between bacterial infection and other kinds of inflammatory processes? Rheum Dis 62:337–340CrossRef Delevaux I, Andre M, Colombier M, Albuisson E, Meylheuc F, Bégueet RJ (2003) Can procalcitonin measurement help in differentiating between bacterial infection and other kinds of inflammatory processes? Rheum Dis 62:337–340CrossRef
Metadata
Title
Significantly higher procalcitonin levels could differentiate Gram-negative sepsis from Gram-positive and fungal sepsis
Authors
Helena Brodská
Karin Malíčková
Václava Adámková
Hana Benáková
Markéta Marková Šťastná
Tomáš Zima
Publication date
01-08-2013
Publisher
Springer Milan
Published in
Clinical and Experimental Medicine / Issue 3/2013
Print ISSN: 1591-8890
Electronic ISSN: 1591-9528
DOI
https://doi.org/10.1007/s10238-012-0191-8

Other articles of this Issue 3/2013

Clinical and Experimental Medicine 3/2013 Go to the issue